Beryl Drugs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/08/2025 ,inter alia, to consider and approve the unaudited financial results ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Beryl Drugs Ltd has informed BSE that its Board of Directors will meet on Thursday, 7 August 2025 at 2:00 PM at the registered office in Indore. The key agenda is to consider and approve the unaudited financial results for the quarter ended 30 June 2025 (Q1 FY2025-26). The board will also take on record the Limited Review Report from the auditors for the same period. The filing is made under Regulation 29(1)(a) of SEBI LODR Regulations, 2015 as a standard advance intimation. No actual financial numbers have been disclosed in this notice.
This is a routine pre-results intimation and does not itself move the stock, but the actual Q1 numbers released on or after 7 August could trigger price action. Retail investors should watch the results announcement for revenue, profit, and margin trends in this small-cap pharma company.